Clinical Trial Update: Baricitinib in Idiopathic Granulomatous Mastitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating baricitinib for idiopathic granulomatous mastitis; status is Active, not Recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Granulomatous Mastitis
• Mastitis

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: First Affiliated Hospital of Zhejiang University | Conditions: Mastitis Chronic, Idiopathic Granulomatous Mastitis | Phase 2 | Status: ACTIVE_NOT_RECRUITING